Inhalational monkeypox virus infection in cynomolgus macaques.
An inhalation exposure system was characterized to deliver aerosolized monkeypox virus (MPXV), and a non-human primate (NHP) inhalation monkeypox model was developed in cynomolgus macaques. A head-only aerosol exposure system was characterized, and two sampling methods were evaluated: liquid impingement via an impinger and impaction via a gelatin filter. The aerosol concentrations obtained with the gelatin filter and impinger were virtually identical, indicating that either method is acceptable for sampling aerosols containing MPXV. The mass median aerodynamic diameter (MMAD) for individual aerosol tests in the aerosol system characterization and the NHP study ranged from 1.08 to 1.15 μm, indicating that the aerosol particles were of a sufficient size to reach the alveoli. Six cynomolgus macaques (four male and two female) were used on study. The animals were aerosol exposed with MPXV and received doses between 2.51 × 10(4) to 9.28 × 10(5) plaque forming units (PFUs) inhaled. Four of the six animals died or were euthanized due to their moribund conditions. Both animals that received the lowest exposure doses survived to the end of the observation period. The inhalation LD(50) was determined to be approximately 7.8 × 10(4) pfu inhaled. These data demonstrate that an inhalation MPXV infection model has been developed in the cynomolgus macaque with disease course and lethal dose similar to previously published data.
Battelle, Columbus OH, USA. barnewallr@battelle.org
Roy E
RE
Barnewall
David A
DA
Fisher
Ashley B
AB
Robertson
Pauline A
PA
Vales
Katherine A
KA
Knostman
John E
JE
Bigger
D000336:Aerosols; D000391:Air Microbiology; D000818:Animals; D005260:Female; D019570:Inhalation Exposure; D007928:Lethal Dose 50; D008251:Macaca; D008297:Male; D045908:Mpox, Monkeypox / Q000473:pathology* / Q000821:virology*; D008993:Monkeypox virus / Q000472:pathogenicity*; D010316:Particle Size; D016019:Survival Analysis
D000336:Aerosols